Lomitapide Medylate

Category: Cholesterol



Lomitapide Medylate Overview

Lomitapide (INN, marketed as Juxtapid in the US and as Lojuxta in the EU) is a drug used as a lipid-lowering agent for the treatment of familial hypercholesterolemia, developed by Aegerion Pharmaceuticals.[1] It has been tested in clinical trials as single treatment and in combinations with atorvastatin, ezetimibe and fenofibrate.[2][3] The US Food and Drug Administration (FDA) approved lomitapide on 21 December 2012, as an orphan drug to reduc...

Read more Lomitapide Medylate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lomitapide

Recent Lomitapide Medylate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Lomitapide Medylate
  • Capsule: 10mg, 20mg, 30mg, 40mg, 5mg, 60mg
  • Capsule, Hard Gelatin: 5 mg, 10 mg, and 20 mg.
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Lomitapide Medylate or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA